Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Nektar And PureTech Merger Talks Terminated
Discussions Could Have Caused 'Extended Period Of Uncertainty'
Oct 10 2022
•
By
Kevin Grogan
Nektar and Puretech jump off the biotech M&A merry-go-round for now • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business